Cutaneous Hydration Assessment in Sickle Cell Disease

About the study

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

Study point of contact

Enrico Novelli, MD
412-916-3416
[email protected]
Manzoor Mohideen, PhD
412-648-6920
[email protected]

Locations

1 United States site

Age

> 12 Years

Phase

Not Applicable

Study type

Interventional

Gender

All

Interventions

Device

participation requirements

Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
Participants must be ≥12-years old
Participants that provide legally effective consent to all study procedures

participation restrictions

Participants under 12-years old
Participants being treated with experimental therapies in clinical trials

Locations

  • Pittsburgh, Pennsylvania, United States, UPMC Sickle Cell Clinic
Last updated 2022-04-06